In the field of hematologic malignancies, every breakthrough in formulation and delivery technology represents the opening of a new door toward more convenient and safer treatment for patients. Darzalex Faspro® (generic name: daratumumab, subcutaneous injection), with its unique advantage as the world’s first, China’s first, and currently the only subcutaneous anti-CD38...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)